Verition Fund Management LLC Chemo Centryx, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $1.5 Million - $3.5 Million
67,549 New
67,549 $3.49 Million
Q3 2021

Nov 15, 2021
SELL
$13.18 - $19.83 $352,037 - $529,659
-26,710 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.59 - $50.88 $117,362 - $622,669
12,238 Added 84.56%
26,710 $358,000
Q1 2021

May 18, 2021
BUY
$49.53 - $68.4 $716,798 - $989,884
14,472 New
14,472 $741,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email